Titan Pharmaceuticals, Inc. (TTNP)

Product Pipeline

PROBUPHINE^® (buprenorphine) Implant

for the treatment of Opioid Addiction

Preclinical	Phase 1	Phase 2	Phase 3	Market
Market completed	Market completed	Market completed	Market completed	Market in progress

More About PROBUPHINE^® (buprenorphine) Implant

Product Pipeline

Ropinirole Implant

for the treatment of Parkinson's Disease

Preclinical	Phase 1	Phase 2	Phase 3	Market
Phase 1 completed	Phase 1 in progress	Phase 1 not started	Phase 1 not started	Phase 1 not started

More About Ropinirole Implant

Product Pipeline

T3 Implant

for the treatment of Hypothyroidism

Preclinical	Phase 1	Phase 2	Phase 3	Market
Preclinical in progress	Preclinical not started	Preclinical not started	Preclinical not started	Preclinical not started

More About T3 Implant

About

Titan Pharmaceuticals

Titan is advancing the treatment of select chronic diseases by developing therapeutics based on its proprietary long-term, continuous drug delivery platform, ProNeura.

More About Titan Pharmaceuticals

Proneura™

Read an article by Fortune and watch Chief Scientific Officer Dr. Kate Beebe-DeVarney explain the advantages of the ProNeura long-term continuous drug delivery platform.

Visit Fortune

Watch the Mechanism of Action video for the ProNeura technology platform and learn how continuous drug release maintains stable blood levels of medication to help treat chronic diseases.

Watch MOA Video